InVivoMAb anti-human IFNgamma
BE0245
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human IFNgamma
- Delivery Days Customer7
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDB27
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Ruggiero E, Nicolay JP, Fronza R, et al. High-resolution analysis of the human T-cell receptor repertoire. Nat Commun. 2015,6:8081. doi: 10.1038/ncomms9081Read this paper
- Herr F, Lemoine R, Gouilleux F, et al. IL-2 phosphorylates STAT5 to drive IFN-γ production and activation of human dendritic cells. J Immunol. 2014,192(12):5660-70. doi: 10.4049/jimmunol.1300422Read this paper
- Qiu X, Wong G, Fernando L, et al. mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med. 2013,5(207):207ra143. doi: 10.1126/scitranslmed.3006605Read this paper
- Soghoian DZ, Jessen H, Flanders M, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med. 2012,4(123):123ra25. doi: 10.1126/scitranslmed.3003165Read this paper
- Nigam P, Kwa S, Velu V, et al. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J Immunol. 2011,186(2):745-53. doi: 10.4049/jimmunol.1002807Read this paper
